![Richard J. White](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard J. White
Technik-/Wissenschafts-/F&E-Leiter bei
Vicuron Pharmaceuticals LLC
Profil
Richard J.
White is currently a Director at Indel Therapeutics, Inc. and previously served as the Chief Scientific Officer & EVP at Vicuron Pharmaceuticals LLC.
He was also the Vice President-Infectious Diseases at Bristol Myers Squibb Co. from 1985 to 1997.
Additionally, he served as the Chairman of F2G Ltd. from 2010 to 2018 and held positions as a Principal at Lederle Laboratories and Glaxo Group Research Ltd. He earned a doctorate from the University of Oxford and an undergraduate degree from The University of Manchester.
Aktive Positionen von Richard J. White
| Unternehmen | Position | Beginn |
|---|---|---|
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1997 |
Indel Therapeutics, Inc.
 Indel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Direktor/Vorstandsmitglied | 29.04.2011 |
Ehemalige bekannte Positionen von Richard J. White
| Unternehmen | Position | Ende |
|---|---|---|
F2G Ltd.
 F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Vorsitzender | 01.12.2018 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.1997 |
Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | - |
Glaxo Group Research Ltd. | Corporate Officer/Principal | - |
Lederle Laboratories
 Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Provides testing services | Corporate Officer/Principal | - |
Ausbildung von Richard J. White
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
88
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Manchester
 The University of Manchester Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
F2G Ltd.
F2G Ltd. Pharmaceuticals: MajorHealth Technology Engages in research and development of novel drugs for life-threatening systemic fungal diseases treatment | Health Technology |
Lederle Laboratories
Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Provides testing services | Commercial Services |
Glaxo Group Research Ltd. | |
Indel Therapeutics, Inc.
Indel Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. |
Wählen Sie MarketScreener 
